Floatz logo

Rituximab

MALT Lymphoma

City of Hope Medical Centermonoclonal_antibodyPhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
89/ 100

Competitive context

32 Active assets in the MALT Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
SWOG Cancer Research Network
Phase 2BBB
Dexasone
Izidore Lossos, MD
Phase 2BBB
Etoposide
Fred Hutchinson Cancer Center
Phase 2BB
Vincristine Sulfate
SWOG Cancer Research Network
Phase 2BB
Fludarabine
UNC Lineberger Comprehensive Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Rituximab is also rated in:

lymphoblastic lymphomaActive
BBB
Indicative · Phase 4
75 / 100
View asset →
grade III lymphomatoid granulomatosisDormant
BBB
Indicative · Phase 2
74 / 100
View asset →
testicular lymphomaDormant
BBB
Indicative · Phase 2
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →